MX9801057A - Derivados de 1-[2-(2,3-dihidro-1h-inden-1-il)etil]-4-(naftalen-1-il)piper azina, preparacion de los mismos, y su uso farmaceutico. - Google Patents

Derivados de 1-[2-(2,3-dihidro-1h-inden-1-il)etil]-4-(naftalen-1-il)piper azina, preparacion de los mismos, y su uso farmaceutico.

Info

Publication number
MX9801057A
MX9801057A MX9801057A MX9801057A MX9801057A MX 9801057 A MX9801057 A MX 9801057A MX 9801057 A MX9801057 A MX 9801057A MX 9801057 A MX9801057 A MX 9801057A MX 9801057 A MX9801057 A MX 9801057A
Authority
MX
Mexico
Prior art keywords
perazine
inden
naphthalen
dihydro
derivatives
Prior art date
Application number
MX9801057A
Other languages
English (en)
Other versions
MXPA98001057A (es
Inventor
Pascal George
Mireille Sevrin
Philippe Manoury
Michel Peynot
Daniele De Peretti
Jean Francois Gibert
Arlette Tixidre
David Machnik
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of MX9801057A publication Critical patent/MX9801057A/es
Publication of MXPA98001057A publication Critical patent/MXPA98001057A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/033—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

Abstract

Compuestos que corresponden a la formula general (I): en donde X representa un átomo de hidrogeno, un grupo hidroxilo, un grupo alcoxi de 1 a 3 átomos de carbono, o un grupo ciclopropilmetoxi, e Y representa 1 átomo de hidrogeno, un grupo hidroxilo, o un grupo metoxi. Aplicacion en terapia.
MXPA/A/1998/001057A 1995-08-09 1998-02-06 Derivados de 1-[2-(2,3-dihidro-1h-inden-1-il)etil]-4-(naftalen-1-il)piperazina, preparacion de losmismos, y su uso farmaceutico MXPA98001057A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR95/09684 1995-08-09
FR9509684 1995-08-09
FR9509684A FR2737724B1 (fr) 1995-08-09 1995-08-09 Derives de 1-[2-(2,3-dihydro-1h-inden-1-yl)ethyl]-4- (naphtalen-1-yl) piperazine, leur preparation et leur application en therapeutique
PCT/FR1996/001216 WO1997006155A1 (fr) 1995-08-09 1996-08-01 Derives de 1-[2-(2,3-dihydro-1h-inden-1-yl)ethyl]-4-(naphtalen-1-yl)piperazine, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
MX9801057A true MX9801057A (es) 1998-05-31
MXPA98001057A MXPA98001057A (es) 1998-10-23

Family

ID=

Also Published As

Publication number Publication date
NO980529D0 (no) 1998-02-06
AR003222A1 (es) 1998-07-08
PL324966A1 (en) 1998-06-22
WO1997006155A1 (fr) 1997-02-20
HUP9802546A3 (en) 1999-10-28
AU6705396A (en) 1997-03-05
EP0843670A1 (fr) 1998-05-27
KR19990035954A (ko) 1999-05-25
FR2737724B1 (fr) 1997-09-05
NO980529L (no) 1998-04-14
JP2000501699A (ja) 2000-02-15
ZA966772B (en) 1997-02-19
AU707372B2 (en) 1999-07-08
BR9609977A (pt) 1999-01-12
FR2737724A1 (fr) 1997-02-14
US5929078A (en) 1999-07-27
HUP9802546A2 (hu) 1999-02-01
CA2228843A1 (en) 1997-02-20
SK16798A3 (en) 1998-08-05
IL123187A0 (en) 1998-09-24
NZ315363A (en) 1998-10-28
CO4750833A1 (es) 1999-03-31
CZ36898A3 (cs) 1998-05-13
CN1199398A (zh) 1998-11-18

Similar Documents

Publication Publication Date Title
MY119150A (en) Azetidine derivatives, their preparation and medicaments containing them
LU93229I2 (fr) "pitolisant et ses sels pharmaceutiquement acceptables, tel que chlorhydrate"
CA2210022A1 (en) Paroxetine hydrochloride solvates
IL116122A0 (en) Intermediates to heterocyclic-cyclic amine derivatives
ATE206611T1 (de) Verwendung von mangiferin oder seinen derivaten zur kosmetischen anwendung
CA2238845A1 (fr) Nouveaux derives de 2,3,5-trimethyl-4-hydroxy anilides, leur preparation et leur application en therapeutique
AU2936195A (en) Cyclic amide derivatives for protecting against ultraviolet rays
HK1034508A1 (en) Substituted beta-alanines.
BG101220A (en) N-substituted 3-azabicyclo (93.2.0) heptane derivatives,their preparation and use
GB2311780B (en) Pharmaceutical Piperazine Compounds
MX9801057A (es) Derivados de 1-[2-(2,3-dihidro-1h-inden-1-il)etil]-4-(naftalen-1-il)piper azina, preparacion de los mismos, y su uso farmaceutico.
ZA958861B (en) 6-polyfluroalkoxy- and 6-polyfluoroalkyl-2-aminobenzothiazole derivatives
AU6991696A (en) 3-beta-aminoazabicyclo-octane or -nonane naphthamide derivatives as antipsychotic agents
NO308002B1 (no) N-p-halogenbenzoylmetylderivater av 4-(p-fluorfenyl)-3-[[3,4- metylendioksy)fenoksy]metyl]piperidin, farmasøytisk preparat inneholdende slike derivater, og anvendelse derav
YU6996A (sh) Upotreba benzotiofena za dobijanje leka
MX9701327A (es) Metodos para inhibir el cancer endometrial.
EP0820760A3 (de) Verwendung von Aldehyden zum Färben von keratinhaltigen fasern
PL317538A1 (en) Intermediate compound for obtaining a pharmaceutically active compound
NO970787D0 (no) Fremgangsmåte for hemming av primær endometrial hyperplasi
TW354309B (en) Tertiary aminosiloxane polymer and process for preparing the same
HU9500710D0 (en) Ureido-acetamide derivatives, preparation thereof and drugs containing same
DE60008890D1 (de) Herstellung von amimide abgeleitet von 6-hydroxy-2,5,7,8-tetramethylchroman-2-säure
MX9803271A (es) Uso de la 1-(2-naft-2-iletil)-4-(3-trifluorometilfenil)-1,2,6-tetrahid ropiridina para la preparacion de farmacos para el tratamiento de esclerosis lateral aminotrofica.